Performance overview
Value at beginning of month: $120,535.66
Value at end of month: $114,071.00
Month over month change: -5.36%
Total CAGR: 15.33%
Related indices, monthly change
NASDAQ: +2.18%
IVV (iShares Core S&P 500): +2.64%
IBB (iShares NASDAQ Biotechnology Index): +0.31%
MXI (iShares Global Materials): +0.06%
VEGI (iShares MSCI Global Agriculture Producers): -0.28%
ICLN (iShares Clean Energy): -5.05%
Individual performances
Calyxt and Intrexon showed modest losses after disappointing Q3 results, which dragged the index to a negative performance for the month. Few of the companies had positive results, and Amyris led the pack up 15%.
Changes made to index
None, you can view the index here.
Allocation as of December 1, 2017
